ESPLANADE SURGERY — All Prescriptions & Medications — Page 11
Practice Code: J84005 | RYDE, PO33 2EH
Showing results 501-550 of 579
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Lisdexamfetamine dimesylate | 15 | 616 | £1.3K | -87.4% ▼ |
| Analgesics with anti-emetics | 15 | 412 | £129 | +6.0% ▲ |
| Doxycycline monohydrate | 15 | 420 | £239 | +38.1% ▲ |
| Dienogest | 15 | 560 | £390 | +107.2% ▲ |
| Medroxyprogesterone acetate | 15 | 598 | £459 | +70.0% ▲ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 15 | 128.0K | £2.6K | -78.6% ▼ |
| Fusidic acid | 15 | 75 | £301 | +45.2% ▲ |
| Cocois | 15 | 1,260 | £193 | +9.2% ▲ |
| Adapalene | 15 | 675 | £234 | -31.5% ▼ |
| Brimonidine tart (Rosacea) | 15 | 870 | £928 | +190.5% ▲ |
| Chlorhexidine gluconate | 15 | 7,750 | £138 | -49.2% ▼ |
| 15 | 110 | £232 | +2.7% ▲ | |
| 15 | 990 | £3.3K | -38.4% ▼ | |
| Mebeverine hydrochloride compound preparations | 14 | 735 | £640 | +23.8% ▲ |
| Midazolam hydrochloride | 14 | 54 | £1.2K | -2.9% ▼ |
| Biphasic insulin lispro | 14 | 160 | £992 | -67.4% ▼ |
| Somatropin | 14 | 42 | £3.1K | -1.2% vs avg |
| Lanreotide | 14 | 14 | £7.7K | +51.8% ▲ |
| Powder amino acid formula (0913107) | 14 | 44.0K | £2.8K | -57.6% ▼ |
| Pilocarpine hydrochloride | 14 | 140 | £457 | +36.4% ▲ |
| 14 | 790 | £4.2K | +118.0% ▲ | |
| 14 | 40 | £150 | -54.9% ▼ | |
| Alverine citrate | 13 | 1,260 | £77 | -68.6% ▼ |
| Budesonide | 13 | 582 | £788 | -17.0% ▼ |
| Eprosartan | 13 | 364 | £177 | -35.6% ▼ |
| Theophylline | 13 | 1,064 | £539 | -84.5% ▼ |
| Levomepromazine maleate | 13 | 105 | £28 | +41.6% ▲ |
| Quinine bisulfate | 13 | 476 | £86 | -66.5% ▼ |
| Saxagliptin | 13 | 364 | £390 | -61.1% ▼ |
| Avanafil | 13 | 52 | £266 | +107.1% ▲ |
| Triptorelin | 13 | 13 | £2.7K | -38.4% ▼ |
| Other phosphate supplement preparations | 13 | 2,340 | £440 | +113.0% ▲ |
| Ready to serve 1.5 kcal/ml milkshake (0913021) | 13 | 156.0K | £3.8K | +21.8% ▲ |
| Prednisolone sodium phosphate | 13 | 830 | £514 | +1.9% vs avg |
| 13 | 130 | £375 | +106.1% ▲ | |
| 13 | 166 | £309 | -7.3% ▼ | |
| Sucralfate | 12 | 2,256 | £2.6K | +42.9% ▲ |
| Oxcarbazepine | 12 | 2,142 | £980 | -57.1% ▼ |
| Rifaximin | 12 | 672 | £3.1K | -55.3% ▼ |
| Canagliflozin | 12 | 342 | £426 | -91.6% ▼ |
| Ibandronic acid | 12 | 336 | £312 | -67.0% ▼ |
| Oral rehydration salts | 12 | 90 | £40 | -58.5% ▼ |
| 12 | 327.0K | £6.2K | +32.3% ▲ | |
| Piroxicam | 12 | 680 | £148 | +75.5% ▲ |
| Azelastine hydrochloride | 12 | 286 | £130 | +7.1% ▲ |
| Betamethasone esters | 12 | 980 | £113 | -80.1% ▼ |
| 12 | 21 | £128 | -32.4% ▼ | |
| 12 | 90 | £137 | -27.3% ▼ | |
| 12 | 1,650 | £237 | -69.5% ▼ | |
| 12 | 630 | £2.5K | -73.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.